Compare Summit Therapeutics Inc (SMMT) vs TORM plc (TRMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs TORM plc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while TORM plc trades at $29.89 (market cap $2.99B). The key difference: Summit Therapeutics Inc is far larger — about 3.5× TORM plc's market cap, and TORM plc pays a 9.62% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | TRMD | |
|---|---|---|
Market Cap | $10.48B | $2.99B |
Sector | Health | Technology |
52-Week High | $29.32 | $34.87 |
52-Week Low | $13.05 | $17.50 |
Enterprise Value | $9.90B | $3.88B |
Dividend Yield | — | 9.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →
